Login / Signup

Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer.

Shi-Ping YangKe LiuYang LiGuan-Qiao LiJia-Yi LiYu-Yi LinSan-Gang Wu
Published in: Expert review of molecular diagnostics (2024)
The 21-gene RS assay is an important prognostic factor in patients with dnMBC.
Keyphrases
  • prognostic factors
  • metastatic breast cancer
  • copy number
  • genome wide
  • genome wide identification
  • type diabetes
  • gene expression
  • insulin resistance
  • genome wide analysis
  • weight loss